High cytotoxic activity of ZnO@leucovorin nanocomposite based materials against an MCF-7 cell model-Reference-Cited by-同舟云学术

High cytotoxic activity of ZnO@leucovorin nanocomposite based materials against an MCF-7 cell model

Published:2020 Issue:16 Volume:12 Page:2176-2184
ISSN:1759-9660
Container-title:Analytical Methods
language:en
Short-container-title:Anal. Methods

Author:

Sanad Mohamed Fathi¹²³⁴⁵,Abu Serea Esraa Samy⁶²⁷⁵⁸,Bazid Shereen Magdy⁹¹⁰¹¹⁵,Nabih Shimaa⁹¹⁰¹¹⁵,Ahsan Md Ariful¹²¹³¹⁴^ORCID,Shalan Ahmed Esmail¹⁵¹⁶⁵⁸¹⁷^ORCID

Affiliation:

1. Chemistry Department

2. Faculty of Science

3. Ain-Shams University

4. Abbasia

5. Egypt

6. Chemistry & Biochemistry Department

7. Cairo University

8. BCMaterials—Basque Center for Materials, Applications, and Nanostructures

9. Basic Science Departments

10. Modern Academy for Engineering and Technology

11. Maadi

12. The University of Texas at El Paso

13. El Paso

14. USA

15. Central Metallurgical Research and Development Institute (CMRDI)

16. Helwan

17. Leioa 48940

Abstract

In the current work, we design a multifunctional hybrid nanocomposite for treating MCF-7 cell lines, which act as a model for breast cancer cells, to overcome the serious side-effects of chemotherapy treatment pathways.

Funder

Ministerio de Economía y Competitividad

Publisher

Royal Society of Chemistry (RSC)

Subject

General Engineering,General Chemical Engineering,Analytical Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2020/AY/D0AY00498G

Reference54 articles.

1. Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019

2. Assessing the Potential of Chitosan/Polylactide Nanoparticles for Delivery of Therapeutics for Triple-Negative Breast Cancer Treatment

3. In vivo β-catenin attenuation by the integrin α5-targeting nano-delivery strategy suppresses triple negative breast cancer stemness and metastasis